PHGE — Biomx Cashflow Statement
0.000.00%
- $15.25m
- $17.04m
Annual cashflow statement for Biomx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -30.1 | -36.2 | -28.3 | -26.2 | -17.7 |
Depreciation | |||||
Non-Cash Items | 3.01 | 2.98 | 1.13 | 1.54 | -18.1 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.453 | 3.1 | -4.43 | 2.48 | -2.99 |
Change in Accounts Receivable | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -24.4 | -27.6 | -29.1 | -21.3 | -37 |
Capital Expenditures | -1.01 | -3.68 | -0.112 | -0.05 | -0.03 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -9.85 | 19.9 | -2 | 2 | 0.745 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Cash from Investing Activities | -10.9 | 16.2 | -2.11 | 1.95 | 0.715 |
Financing Cash Flow Items | -0.075 | — | — | -0.333 | 20.4 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.134 | 37.3 | 0.292 | 2.9 | 38.4 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -35.2 | 25.9 | -30.8 | -16.4 | 2.11 |